(S)-5-[3-(2-Piperidin-1-yl-ethoxy)-phenyl]-11,12-dihydro-5H-6,13-dioxa-benzo[3,4]cyclohepta[1,2-a]naphthalene-2,8-diol

ID: ALA1087041

PubChem CID: 44596687

Max Phase: Preclinical

Molecular Formula: C30H31NO5

Molecular Weight: 485.58

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Oc1ccc2c(c1)O[C@@H](c1cccc(OCCN3CCCCC3)c1)C1=C2CCOc2cc(O)ccc21

Standard InChI:  InChI=1S/C30H31NO5/c32-21-8-10-26-27(18-21)35-15-11-25-24-9-7-22(33)19-28(24)36-30(29(25)26)20-5-4-6-23(17-20)34-16-14-31-12-2-1-3-13-31/h4-10,17-19,30,32-33H,1-3,11-16H2/t30-/m0/s1

Standard InChI Key:  XGYIXXBEYYYIGU-PMERELPUSA-N

Molfile:  

     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
   15.6023  -26.4360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6012  -27.2621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3148  -27.6743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3130  -26.0240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0272  -26.4324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0306  -27.2642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7487  -27.6748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4679  -27.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9863  -24.6226    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4653  -26.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7418  -26.0113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6139  -25.1478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1636  -24.5615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4780  -25.2786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2450  -26.1130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8505  -26.7298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6892  -26.5135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9190  -25.6748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3119  -25.0615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7602  -25.4541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1820  -27.6685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1803  -28.4922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8937  -28.9023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6070  -28.4889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6025  -27.6609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8886  -27.2545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8875  -27.6733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.3135  -27.2450    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.0292  -27.6527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7400  -27.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4558  -27.6445    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4560  -28.4669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1675  -28.8745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8809  -28.4621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8781  -27.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1620  -27.2253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16 17  2  0
  7  8  1  0
 17 18  1  0
  8 10  1  0
 18 19  2  0
 19 14  1  0
  5  4  2  0
 18 20  1  0
  4  1  1  0
  8 21  1  6
  5  6  1  0
 21 22  2  0
 22 23  1  0
  2  3  1  0
 23 24  2  0
 14  9  1  0
 24 25  1  0
 15 10  1  0
 25 26  2  0
 26 21  1  0
 11 12  1  0
  2 27  1  0
 12 13  1  0
 25 28  1  0
 13  9  1  0
 28 29  1  0
 10 11  2  0
 29 30  1  0
  3  6  2  0
 30 31  1  0
 31 32  1  0
  1  2  2  0
 14 15  2  0
  5 11  1  0
 15 16  1  0
  6  7  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1087041

   (19S)-19-[3-(2-piperidin-1-ylethoxy)phenyl]-8,18-dioxatetracyclo[9.8.0.02,7.012,17]nonadeca-1(11),2(7),3,5,12(17),13,15-heptaene-5,15-diol

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 485.58

Molecular Weight (Monoisotopic): 485.2202

AlogP: 5.79

#Rotatable Bonds: 5

Polar Surface Area: 71.39

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.88

CX Basic pKa: 8.40

CX LogP: 4.29

CX LogD: 3.81

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.48

Np Likeness Score: 0.02

References

1. Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z..  (2009)  Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.,  52  (23): [PMID:19366247] [10.1021/jm900146e]

Source

Source(1):

• Scientific Literature